UK Earnings, Trading Statements Calendar - Week Ahead
23rd Apr 2014 15:29
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Wednesday.<br />-------<br /><strong>FTSE 100 - WINNERS</strong><br />-------<br /><strong>Associated British Foods</strong>, up 8.9%. The food, ingredients and retail group r Read More
LONDON (Alliance News) - The following UK shares received analyst recommendations Wednesday morning:<br />----------<br /><strong>FTSE 100</strong><br />----------<br />CREDIT SUISSE RAISES WOLSELEY TO 'OUTPERFORM' ('NEUTRAL') - TARGET 4000 (3400) PENCE <br />----------<br />TRADERS: CREDIT SU Read More
LONDON (Alliance News) - UK shares are flat to higher Wednesday following a firm close in the US. <br /><br />Several UK blue-chips and mid-caps - including <strong>Reed Elsevier</strong>, <strong>ARM Holdings</strong> and <strong>MoneySupermarket.com</strong> - sought to provide reassurance a Read More
LONDON (Alliance News) - UK equities closed mixed Tuesday, with large- and mid-cap stocks outperforming their smaller peers to end the day in positive territory for the third trading day in a row, as individual company news took centre stage.<br /><br />Following a four-day Easter break, Londo Read More
LONDON (Alliance News) - GlaxoSmithKline PLC said Tuesday that, along with Theravance Inc, it will be launching a phase III study for the combination treatment of fluticasone furoate/vilanterol for chronic obstructive pulmonary disease. Glaxo said that positive results from the study would Read More
LONDON (Alliance News) - Pharmaceutical stocks are reigning over the first session following the long Easter bank holiday, with mergers and acquisitions leading investor interest.<br /><br /><strong>GlaxoSmithKline</strong> has signed a three-part inter-conditional transaction with Swiss healt Read More
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Tuesday.<br />-------<br /><strong>FTSE 100 - WINNERS</strong><br />-------<br /><strong>AstraZeneca</strong>, up 7.1%. The pharmaceutical company has jumped after The Sunday Read More
LONDON (Alliance News) - The following is a summary of top news stories Tuesday.<br />----------<br /><strong>COMPANIES</strong><br />----------<br /><strong>GlaxoSmithKline</strong> PLC said it has signed a three-part inter-conditional transaction with Novartis AG which will see it sell off i Read More
LONDON (Alliance News) - Pharmaceutical companies are leading UK stocks higher Tuesday, with the sector buoyed by merger and acquisition activity and speculation. With little in the way of economic data to provide focus, and in the absence of a further deterioration of the political situati Read More
LONDON (Alliance News) - UK shares have opened slightly higher Tuesday following gains on Wall Street over the long Easter weekend. <br /><br />Merger and acquisition activity and discussion surrounding UK pharmaceutical giants <strong>GlaxoSmithKline</strong> and <strong>AstraZeneca</strong> Read More
LONDON (Alliance News) - GlaxoSmithKline PLC said Tuesday it has signed a three-part inter-conditional transaction with Novartis AG which will see it sell off its Oncology portfolio, acquire Novartis' global Vaccines business, and create a dually-offered Consumer Healthcare business. The tr Read More
LONDON (Alliance News) - UK stocks are set to open marginally higher Tuesday, as European markets play catch-up with Wall Street, which made gains over the long Easter weekend despite ongoing tensions in Ukraine. Spreadbetters are indicating that the FTSE 100 will open slightly higher Tuesd Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Thursday said a group of executives including Chief Executive Officer Andrew Witty acquired shares and American Depositary Shares under the company performance share plan at a price of 1581.50 pence per share and USD52.55 per ADS Wednesday.<br /><br Read More
LONDON (Alliance News) - GlaxoSmithKline PLC said Tuesday it has signed a three-part inter-conditional transaction with Novartis AG which will see it sell off its Oncology portfolio, acquire Novartis' global Vaccines business, and create a dually-offered Consumer Healthcare business. The tr Read More
LONDON (Alliance News) - GlaxoSmithKline PLC said Thursday that its Incruse Ellipta treatment had been granted marketing authorisation in Canada for the treatment of chronic obstructive pulmonary disease. Incruse Ellipta contains 62.5 micrograms of umeclidinium delivered by the Ellipta dry Read More
LONDON (Alliance News) - <strong>RSA Insurance Group</strong> Chief Executive Stephen Hester Thursday went a long way to meeting his asset disposal target, selling the insurer's Polish and Baltic operations as part of its efforts to shore up its balance sheet in the wake of big losses in Irela Read More
LONDON (Alliance News) - GlaxoSmithKline PLC confirmed that it was investigating allegations of misconduct in its Jordan and Lebanon operations in a statement Wednesday, the latest in a series of mounting investigations across its business. The pharmaceutical giant is currently investigatin Read More
LONDON (Alliance News) - The following UK shares received analyst recommendations Thursday morning:<br />----------<br /><strong>FTSE 100</strong><br />----------<br />JEFFERIES CUTS WILLIAM HILL TO 'HOLD' ('BUY') <br />----------<br />GOLDMAN CUTS IMPERIAL TOBACCO TO 'BUY' ('CONVICTION BUY LI Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Tuesday said it has received US approval for once-weekly type 2 diabetes treatment Tanzeum or albiglutide, with the company now anticipating the US launch of the treatment in the third-quarter of 2014. In a statement, the pharmaceutical giant sai Read More